NFKB1 and pulmonary arterial hypertension: In addition, by using both pharmacological and genetic approaches, we demonstrated that NF-κB was involved in CNH-induced PAH because NF-κB inhibitor treatment ameliorated CNH-induced PAH in mice, whereas NF-κB knockout mice were resistant to CNH-induced PAH.